Trials / Completed
CompletedNCT06301178
Effect of Vitamin D Injection on Hypertrophic Scars and Keloids
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Mostafa Bahaa · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Scars and keloids cause patients severe morbidity and psychological distress. Hypertrophic scars rise above the skin but stay within the scar boundaries, while keloids expand. The development of keloids and hypertrophic scars is a consequence of insufficient wound healing. These lesions are distinguished by excessive ECM deposition. Excessive ECM deposition is caused by increased inflammatory and proliferative processes and decreased remodeling activities. These scarring lesions are also linked to genetic and systemic causes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cholecalciferol | Vitamin D has various critical regulatory roles, including inflammatory control, cellular proliferation and differentiation, and wound healing regulation. |
Timeline
- Start date
- 2024-02-27
- Primary completion
- 2025-02-20
- Completion
- 2025-02-20
- First posted
- 2024-03-08
- Last updated
- 2025-04-08
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06301178. Inclusion in this directory is not an endorsement.